Since a high CD101 expression could potentially predict a malignant phenotype of glioma, we therefore examined the predictive value of CD101 in determining clinical prognosis for glioma patients derived from TCGA database (Figure 3A). The gene discussed is CD101; the disease is central nervous system cancer.